Anderson, M. S., Nadkarni, A., Cardwell, L. A., Alinia, H., & Feldman, S. R. (2017). Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: Safety, efficacy, and patient acceptability. Patient Prefer Adherence.

Anderson, Michael S., Anish Nadkarni, Leah A. Cardwell, Hossein Alinia, und Steven R. Feldman. "Spotlight On Brimonidine Topical Gel 0.33% for Facial Erythema of Rosacea: Safety, Efficacy, and Patient Acceptability." Patient Prefer Adherence 2017.

Anderson, Michael S., et al. "Spotlight On Brimonidine Topical Gel 0.33% for Facial Erythema of Rosacea: Safety, Efficacy, and Patient Acceptability." Patient Prefer Adherence 2017.